VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…
The customised study, commissioned by Fairfest Media and conducted by NielsenIQ, the leader in consumer intelligence, indicated that travel industry…
CU Empowers Students with Global Exposure from Harvard to Walt Disney World CHANDIGARH, India, June 2, 2025 /PRNewswire/ -- Chandigarh:…
New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials SINGAPORE, June…